The unfolded protein response in multiple sclerosis

Frontiers in Neuroscience

Volumn 9, Issue JUL, 2015, Pages

  Stone, Sarrabeth ^a,b   Lin, Wensheng ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Demyelination; Endoplasmic reticulum stress; Experimental autoimmune encephalomyelitis; Multiple sclerosis; Oligodendrocytes; Pancreatic endoplasmic reticulum kinase; Remyelination; Unfolded protein response

Indexed keywords

ENZYME INHIBITOR; GAMMA INTERFERON; GSK 2606414; GSK 2656157; GUANABENZ; INITIATION FACTOR 2ALPHA; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; CELL PROTECTION; DISEASE ASSOCIATION; DRUG MECHANISM; ENDOPLASMIC RETICULUM STRESS; HUMAN; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN UNFOLDING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; UNFOLDED PROTEIN RESPONSE;

EID: 84938520346     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2015.00264     Document Type: Review

References (132)

1. Anitei, M., and Pfeiffer, S. E. (2006). Myelin biogenesis: sorting out protein trafficking. Curr. Biol. 16, R418-R421. doi: 10.1016/j.cub.2006.05.010.
2. Aragon, I. V., Barrington, R. A., Jackowski, S., Mori, K., and Brewer, J. W. (2012). The specialized unfolded protein response of B lymphocytes: ATF6α-independent development of antibody-secreting B cells. Mol. Immunol. 51, 347-355. doi: 10.1016/j.molimm.2012.04.001.
3. Atkins, C., Liu, Q., Minthorn, E., Zhang, S. Y., Figueroa, D. J., Moss, K., et al. (2013). Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity. Cancer. Res. 73, 1993-2002. doi: 10.1158/0008-5472.CAN-12-3109.
4. Axten, J. M., Medina, J. R., Feng, Y., Shu, A., Romeril, S. P., Grant, S. W., et al. (2012). Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK). J. Med. Chem. 55, 7193-7207. doi: 10.1021/jm300713s.
5. Balabanov, R., Strand, K., Goswami, R., McMahon, E., Begolka, W., Miller, S. D., et al. (2007). Interferon-gamma-oligodendrocyte interactions in the regulation of experimental autoimmune encephalomyelitis. J. Neurosci. 27, 2013-2024. doi: 10.1523/JNEUROSCI.4689-06.2007.
6. Bankston, A. N., Mandler, M. D., and Feng, Y. (2013). Oligodendroglia and neurotrophic factors in neurodegeneration. Neurosci. Bull. 29, 216-228. doi: 10.1007/s12264-013-1321-3.
7. Barnett, M. H., and Prineas, J. W. (2004). Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann. Neurol. 55, 458-468. doi: 10.1002/ana.20016.
8. Baxter, A. G. (2007). The origin and application of experimental autoimmune encephalomyelitis. Nat. Rev. Immunol. 7, 904-912. doi: 10.1038/nri2190.
9. Bommiasamy, H., Back, S. H., Fagone, P., Lee, K., Meshinchi, S., Vink, E., et al. (2009). ATF6alpha induces XBP1-independent expansion of the endoplasmic reticulum. J. Cell. Sci. 122, 1626-1636. doi: 10.1242/jcs.045625.
10. Boyce, M., Bryant, K. F., Jousse, C., Long, K., Harding, H. P., Scheuner, D., et al. (2005). A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science 307, 935-939. doi: 10.1126/science.1101902.
11. Bradl, M., and Lassmann, H. (2010). Oligodendrocytes: biology and pathology. Acta Neuropathol. 119, 37-53. doi: 10.1007/s00401-009-0601-5.
12. Brewer, J. W., and Hendershot, L. M. (2005). Building an antibody factory: a job for the unfolded protein response. Nat. Immunol. 6, 23-29. doi: 10.1038/ni1149.
13. Cao, S. S., and Kaufman, R. J. (2014). Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid. Redox Signal. 21, 396-413. doi: 10.1089/ars.2014.5851.
14. Chakrabarty, A., Danley, M. M., and LeVine, S. M. (2004). Immunohistochemical localization of phosphorylated protein kinase R and phosphorylated eukaryotic initiation factor-2 alpha in the central nervous system of SJL mice with experimental allergic encephalomyelitis. J. Neurosci. Res. 76, 822-833. doi: 10.1002/jnr.20125.
15. Chakrabarty, A., Fleming, K. K., Marquis, J. G., and LeVine, S. M. (2005). Quantifying immunohistochemical staining of phospho-eIF2alpha, heme oxygenase-2 and NADPH cytochrome P450 reductase in oligodendrocytes during experimental autoimmune encephalomyelitis. J. Neurosci. Methods 144, 227-234. doi: 10.1016/j.jneumeth.2004.11.010.
16. Chen, Y., and Brandizzi, F. (2013). IRE1: ER stress sensor and cell fate executor. Trends Cell Biol. 23, 547-555. doi: 10.1016/j.tcb.2013.06.005.
17. Colla, E., Jensen, P. H., Pletnikova, O., Troncoso, J. C., Glabe, C., and Lee, M. K. (2012). Accumulation of toxic α-synuclein oligomer within endoplasmic reticulum occurs in α-synucleinopathy in vivo. J. Neurosci. 32, 3301-3305. doi: 10.1523/JNEUROSCI.5368-11.2012.
18. Corbin, J. G., Kelly, D., Rath, E. M., Baerwald, K. D., Suzuki, K., and Popko, B. (1996). Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Mol. Cell Neurosci. 7, 354-370. doi: 10.1006/mcne.1996.0026.
19. Cox, D. J., Strudwick, N., Ali, A. A., Paton, A. W., Paton, J. C., and Schröder, M. (2011). Measuring signaling by the unfolded protein response. Methods Enzymol. 491, 261-292. doi: 10.1016/B978-0-12-385928-0.00015-8.
20. Csala, M., Bánhegyi, G., and Benedetti, A. (2006). Endoplasmic reticulum: a metabolic compartment. FEBS Lett. 580, 2160-2165. doi: 10.1016/j.febslet.2006.03.050.
21. Cunnea, P., Mháille, A. N., McQuaid, S., Farrell, M., McMahon, J., and Fitz Gerald, U. (2011). Expression profiles of endoplasmic reticulum stress-related molecules in demyelinating lesions and multiple sclerosis. Mult. Scler. 17, 808-818. doi: 10.1177/1352458511399114.
22. Cwiklinska, H., Mycko, M. P., Luvsannorov, O., Walkowiak, B., Brosnan, C. F., Raine, C. S., et al. (2003). Heat shock protein 70 associations with myelin basic protein and proteolipid protein in multiple sclerosis brains. Int. Immunol. 15, 241-249. doi: 10.1093/intimm/dxg022.
23. D'Antonio, M., Feltri, M. L., and Wrabetz, L. (2009). Myelin under stress. J. Neurosci. Res. 87, 3241-3249. doi: 10.1002/jnr.22066.
24. Deng, J., Lu, P. D., Zhang, Y., Scheuner, D., Kaufman, R. J., Sonenberg, N., et al. (2004). Translational repression mediates activation of nuclear factor kappa B by phosphorylated translation initiation factor 2. Mol. Cell. Biol. 24, 10161-10168. doi: 10.1128/MCB.24.23.10161-10168.2004.
25. Denic, A., Johnson, A. J., Bieber, A. J., Warrington, A. E., Rodriguez, M., and Pirko, I. (2011). The relevance of animal models in multiple sclerosis research. Pathophysiology 18, 21-29. doi: 10.1016/j.pathophys.2010.04.004.
26. Deslauriers, A. M., Afkhami-Goli, A., Paul, A. M., Bhat, R. K., Acharjee, S., Ellestad, K. K., et al. (2011). Neuroinflammation and endoplasmic reticulum stress are coregulated by crocin to prevent demyelination and neurodegeneration. J. Immunol. 187, 4788-4799. doi: 10.4049/jimmunol.1004111.
27. Doyle, K. M., Kennedy, D., Gorman, A. M., Gupta, S., Healy, S. J., and Samali, A. (2011). Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders. J. Cell. Mol. Med. 15, 2025-2039. doi: 10.1111/j.1582-4934.2011.01374.x.
28. Dutta, R., and Trapp, B. D. (2011). Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog. Neurobiol. 93, 1-12. doi: 10.1016/j.pneurobio.2010.09.005.
29. Fancy, S. P., Chan, J. R., Baranzini, S. E., Franklin, R. J., and Rowitch, D. H. (2011). Myelin regeneration: a recapitulation of development? Annu. Rev. Neurosci. 34, 21-43. doi: 10.1146/annurev-neuro-061010-113629.
30. Ferber, I. A., Brocke, S., Taylor-Edwards, C., Ridgway, W., Dinisco, C., Steinman, L., et al. (1996). Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156, 5-7.
31. Franklin, R. J. (2002). Why does remyelination fail in multiple sclerosis? Nat. Rev. Neurosci. 3, 705-714. doi: 10.1038/nrn917.
32. Franklin, R. J., and Ffrench-Constant, C. (2008). Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 9, 839-855. doi: 10.1038/nrn2480.
33. Frohman, E. M., Racke, M. K., and Raine, C. S. (2006). Multiple sclerosis-the plaque and its pathogenesis. N. Engl. J. Med. 354, 942-955. doi: 10.1056/NEJMra052130.
34. Gade, P., Ramachandran, G., Maachani, U. B., Rizzo, M. A., Okada, T., Prywes, R., et al. (2012). An IFN-γ-stimulated ATF6-C/EBP-β-signaling pathway critical for the expression of Death Associated Protein Kinase 1 and induction of autophagy. Proc. Natl. Acad. Sci. U.S.A. 109, 10316-10321. doi: 10.1073/pnas.1119273109.
35. Gass, J. N., Jiang, H. Y., Wek, R. C., and Brewer, J. W. (2008). The unfolded protein response of B-lymphocytes: PERK-independent development of antibody-secreting cells. Mol. Immunol. 45, 1035-1043. doi: 10.1016/j.molimm.2007.07.029.
36. Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., and Gage, F. H. (2010). Mechanisms underlying inflammation in neurodegeneration. Cell 140, 918-934. doi: 10.1016/j.cell.2010.02.016.
37. Glembotski, C. C. (2014). Roles for ATF6 and the sarco/endoplasmic reticulum protein quality control system in the heart. J. Mol. Cell Cardiol. 71, 11-15. doi: 10.1016/j.yjmcc.2013.09.018.
38. Gold, R., Linington, C., and Lassmann, H. (2006). Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129, 1953-1971. doi: 10.1093/brain/awl075.
39. Goverman, J. (2009). Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 9, 393-407. doi: 10.1038/nri2550.
40. Gow, A., and Wrabetz, L. (2009). CHOP and the endoplasmic reticulum stress response in myelinating glia. Curr. Opin. Neurobiol. 19, 505-510. doi: 10.1016/j.conb.2009.08.007.
41. Harding, H. P., Calfon, M., Urano, F., Novoa, I., and Ron, D. (2002). Transcriptional and translational control in the mammalian unfolded protein response. Annu. Rev. Cell. Dev. Biol. 18, 575-599. doi: 10.1146/annurev.cellbio.18.011402.160624.
42. Harding, H. P., Novoa, I., Bertolotti, A., Zeng, H., Zhang, Y., Urano, F., et al. (2001). Translational regulation in the cellular response to biosynthetic load on the endoplasmic reticulum. Cold Spring Harb. Symp. Quant. Biol. 66, 499-508. doi: 10.1101/sqb.2001.66.499.
43. Harding, H. P., Zhang, Y., and Ron, D. (1999). Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 397, 271-274. doi: 10.1038/16729.
44. Harding, H. P., Zhang, Y., Zeng, H., Novoa, I., Lu, P. D., Calfon, M., et al. (2003). An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol. Cell. 11, 619-633. doi: 10.1016/S1097-2765(03)00105-9.
45. Harding, H. P., Zyryanova, A. F., and Ron, D. (2012). Uncoupling proteostasis and development in vitro with a small molecule inhibitor of the pancreatic endoplasmic reticulum kinase, PERK. J. Biol. Chem. 287, 44338-44344. doi: 10.1074/jbc.M112.428987.
46. Hetz, C. (2012). The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat. Rev. Mol. Cell. Biol. 13, 89-102. doi: 10.1038/nrm3270.
47. Hetz, C., Chevet, E., and Harding, H. P. (2013). Targeting the unfolded protein response in disease. Nat. Rev. Drug Discov. 12, 703-719. doi: 10.1038/nrd3976.
48. Hetz, C., and Mollereau, B. (2014). Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat. Rev. Neurosci. 15, 233-249. doi: 10.1038/nrn3689.
49. Hisahara, S., Araki, T., Sugiyama, F., Yagami, K., Suzuki, M., Abe, K., et al. (2000). Targeted expression of baculovirus p35 caspase inhibitor in oligodendrocytes protects mice against autoimmune-mediated demyelination. EMBO J. 19, 341-348. doi: 10.1093/emboj/19.3.341.
50. Hisahara, S., Okano, H., and Miura, M. (2003). Caspase-mediated oligodendrocyte cell death in the pathogenesis of autoimmune demyelination. Neurosci. Res. 46, 387-397. doi: 10.1016/S0168-0102(03)00127-5.
51. Hövelmeyer, N., Hao, Z., Kranidioti, K., Kassiotis, G., Buch, T., Frommer, F., et al. (2005). Apoptosis of Oligodendrocytes via Fas and TNF-R1 Is a Key Event in the Induction of Experimental Autoimmune Encephalomyelitis. J. Immunol. 175, 5875-5884. doi: 10.4049/jimmunol.175.9.5875.
52. Hu, P., Han, Z., Couvillon, A. D., Kaufman, R. J., and Exton, J. H. (2006). Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression. Mol. Cell. Biol. 26, 3071-3084. doi: 10.1128/MCB.26.8.3071-3084.2006.
53. Hussien, Y., Cavener, D. R., and Popko, B. (2014). Genetic inactivation of PERK signaling in mouse oligodendrocytes: normal developmental myelination with increased susceptibility to inflammatory demyelination. Glia 62, 680-691. doi: 10.1002/glia.22634.
54. Iwakoshi, N. N., Lee, A. H., Vallabhajosyula, P., Otipoby, K. L., Rajewsky, K., and Glimcher, L. H. (2003). Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1. Nat. Immunol. 4, 321-329. doi: 10.1038/ni907.
55. Jiang, H. Y., Wek, S. A., McGrath, B. C., Scheuner, D., Kaufman, R. J., Cavener, D. R., et al. (2003). Phosphorylation of the alpha subunit of eukaryotic initiation factor 2 is required for activation of NF-kappaB in response to diverse cellular stresses. Mol. Cell. Biol. 23, 5651-5663. doi: 10.1128/MCB.23.16.5651-5663.2003.
56. Karin, M., and Lin, A. (2002). NF-kappaB at the crossroads of life and death. Nat. Immunol. 3, 221-227. doi: 10.1038/ni0302-221.
57. Kaufman, R. J. (1999). Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev. 13, 1211-1233. doi: 10.1101/gad.13.10.1211.
58. Kitamura, M. (2011). Control of NF-κB and inflammation by the unfolded protein response. Int. Rev. Immunol. 30, 4-15. doi: 10.3109/08830185.2010.522281.
59. LaFerla, F. M., Sugarman, M. C., Lane, T. E., and Leissring, M. A. (2000). Regional hypomyelination and dysplasia in transgenic mice with astrocyte-directed expression of interferon-gamma. J. Mol. Neurosci. 15, 45-59. doi: 10.1385/JMN:15:1:45.
60. Lassmann, H. (2010). Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models. Exp. Neurol. 225, 2-8. doi: 10.1016/j.expneurol.2009.10.009.
61. Lees, J. R., and Cross, A. H. (2007). A little stress is good: IFN-gamma, demyelination, and multiple sclerosis. J. Clin. Invest. 117, 297-299. doi: 10.1172/JCI31254.
62. Lin, W. (2015). Impaired eIF2B activity in oligodendrocytes contributes to VWMD pathogenesis. Neural. Regen. Res. 10, 195-197 doi: 10.4103/1673-5374.152366.
63. Lin, W., Bailey, S. L., Ho, H., Harding, H. P., Ron, D., Miller, S. D., et al. (2007). The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage. J. Clin. Invest. 117, 448-456. doi: 10.1172/JCI29571.
64. Lin, W., Harding, H. P., Ron, D., and Popko, B. (2005). Endoplasmic reticulum stress modulates the response of myelinating oligodendrocytes to the immune cytokine interferon-gamma. J. Cell. Biol. 169, 603-612. doi: 10.1083/jcb.200502086.
65. Lin, W., Kemper, A., Dupree, J. L., Harding, H. P., Ron, D., and Popko, B. (2006). Interferon-gamma inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress. Brain 129, 1306-1318. doi: 10.1093/brain/awl044.
66. Lin, W., Kemper, A., McCarthy, K. D., Pytel, P., Wang, J. P., Campbell, I. L., et al. (2004). Interferon-gamma induced medulloblastoma in the developing cerebellum. J. Neurosci. 24, 10074-10083. doi: 10.1523/JNEUROSCI.2604-04.2004.
67. Lin, W., Kunkler, P. E., Harding, H. P., Ron, D., Kraig, R. P., and Popko, B. (2008). Enhanced integrated stress response promotes myelinating oligodendrocyte survival in response to interferon-gamma. Am. J. Pathol. 173, 1508-1517. doi: 10.2353/ajpath.2008.080449.
68. Lin, W., and Lin, Y. (2010). Interferon-γ inhibits central nervous system myelination through both STAT1-dependent and STAT1-independent pathways. J. Neurosci. Res. 88, 2569-2577. doi: 10.1002/jnr.22425.
69. Lin, W., Lin, Y., Li, J., Fenstermaker, A. G., Way, S. W., Clayton, B., et al. (2013). Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis. J. Neurosci. 33, 5980-5991. doi: 10.1523/JNEUROSCI.1636-12.2013.
70. Lin, W., and Popko, B. (2009). Endoplasmic reticulum stress in disorders of myelinating cells. Nat. Neurosci. 12, 379-385. doi: 10.1038/nn.2273.
71. Lin, Y., Huang, G., Jamison, S., Li, J., Harding, H. P., Ron, D., et al. (2014a). PERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseases. Am. J. Pathol. 184, 507-519. doi: 10.1016/j.ajpath.2013.10.009.
72. Lin, Y., Jamison, S., and Lin, W. (2012). Interferon-γ activates nuclear factor-κ B in oligodendrocytes through a process mediated by the unfolded protein response. PLoS ONE 7:e36408. doi: 10.1371/journal.pone.0036408.
73. Lin, Y., Pang, X., Huang, G., Jamison, S., Fang, J., Harding, H. P., et al. (2014b). Impaired eukaryotic translation initiation factor 2B activity specifically in oligodendrocytes reproduces the pathology of vanishing white matter disease in mice. J. Neurosci. 34, 12182-12191. doi: 10.1523/JNEUROSCI.1373-14.2014.
74. Lu, P. D., Jousse, C., Marciniak, S. J., Zhang, Y., Novoa, I., Scheuner, D., et al. (2004). Cytoprotection by pre-emptive conditional phosphorylation of translation initiation factor 2. EMBO J. 23, 169-179. doi: 10.1038/sj.emboj.7600030.
75. Marciniak, S. J., and Ron, D. (2006). Endoplasmic reticulum stress signaling in disease. Physiol. Rev. 86, 1133-1149. doi: 10.1152/physrev.00015.2006.
76. Marciniak, S. J., Yun, C. Y., Oyadomari, S., Novoa, I., Zhang, Y., Jungreis, R., et al. (2004). CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev. 18, 3066-3077. doi: 10.1101/gad.1250704.
77. Matsushima, G. K., and Morell, P. (2001). The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 11, 107-116. doi: 10.1111/j.1750-3639.2001.tb00385.x.
78. Maurel, M., Chevet, E., Tavernier, J., and Gerlo, S. (2014). Getting RIDD of RNA: IRE1 in cell fate regulation. Trends Biochem. Sci. 39, 245-554. doi: 10.1016/j.tibs.2014.02.008.
79. McGuire, C., Prinz, M., Beyaert, R., and van Loo, G. (2013). Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology. Trends Mol. Med. 19, 604-613. doi: 10.1016/j.molmed.2013.08.001.
80. McGuire, C., Volckaert, T., Wolke, U., Sze, M., de Rycke, R., Waisman, A., et al. (2010). Oligodendrocyte-specific FADD deletion protects mice from autoimmune-mediated demyelination. J. Immunol. 185, 7646-7653. doi: 10.4049/jimmunol.1000930.
81. McMahon, J. M., McQuaid, S., Reynolds, R., and Fitz Gerald, U. F. (2012). Increased expression of ER stress-and hypoxia-associated molecules in grey matter lesions in multiple sclerosis. Mult. Scler. 18, 1437-1447. doi: 10.1177/1352458512438455.
82. Meares, G. P., Liu, Y., Rajbhandari, R., Qin, H., Nozell, S. E., Mobley, J. A., et al. (2014). PERK-dependent activation of JAK1 and STAT3 contributes to endoplasmic reticulum stress-induced inflammation. Mol. Cell Biol. 34, 3911-3925. doi: 10.1128/MCB.00980-14.
83. Merrill, J. E., Kono, D. H., Clayton, J., Ando, D. G., Hinton, D. R., and Hofman, F. M. (1992). Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc. Natl. Aacd. Sci. U.S.A. 89, 574-578. doi: 10.1073/pnas.89.2.574.
84. Mháille, A. N., McQuaid, S., Windebank, A., Cunnea, P., McMahon, J., Samali, A., et al. (2008). Increased expression of endoplasmic reticulum stress-related signaling pathway molecules in multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 67, 200-211. doi: 10.1097/NEN.0b013e318165b239.
85. Mincheva-Tasheva, S., and Soler, R. M. (2013). NF-κB signaling pathways: role in nervous system physiology and pathology. Neuroscientist 19, 175-194. doi: 10.1177/1073858412444007.
86. Mor, F., and Cohen, I. R. (1992). T cells in the lesion of experimental autoimmune encephalomyelitis. Enrichment for reactivities to myelin basic protein and to heat shock proteins. J. Clin. Invest. 90, 2447-2455. doi: 10.1172/JCI116136.
87. Moreno, J. A., Halliday, M., Molloy, C., Radford, H., Verity, N., Axten, J. M., et al. (2013). Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice. Sci. Transl. Med. 5, 206ra138. doi: 10.1126/scitranslmed.3006767.
88. Mühl, H., and Pfeilschifter, J. (2003). Anti-inflammatory properties of pro-inflammatory interferon-gamma. Int. Immunopharmacol. 3, 1247-1255. doi: 10.1016/S1567-5769(03)00131-0.
89. Mycko, M. P., Papoian, R., Boschert, U., Raine, C. S., and Selmaj, K. W. (2004). Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosis. Clin. Neurol. Neurosurg. 106, 223-229. doi: 10.1016/j.clineuro.2004.02.019.
90. Nave, K. A., and Werner, H. B. (2014). Myelination of the nervous system: mechanisms and functions. Annu. Rev. Cell Dev. Biol. 30, 503-533. doi: 10.1146/annurev-cellbio-100913-013101.
91. Ní Fhlathartaigh, M., McMahon, J., Reynolds, R., Connolly, D., Higgins, E., Fitzgerald, U., et al. (2013). Calreticulin and other components of endoplasmic reticulum stress in rat and human inflammatory demyelination. Acta Neuropathol. Commun. 1:37. doi: 10.1186/2051-5960-1-37.
92. Novoa, I., Zeng, H., Harding, H. P., and Ron, D. (2001). Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha. J. Cell. Biol. 153, 1011-1022. doi: 10.1083/jcb.153.5.1011.
93. Ohri, S. S., Hetman, M., and Whittemore, S. R. (2013). Restoring endoplasmic reticulum homeostasis improves functional recovery after spinal cord injury. Neurobiol. Dis. 58, 29-37. doi: 10.1016/j.nbd.2013.04.021.
94. Panitch, H. S., Hirsch, R. L., Schindler, J., and Johnson, K. P. (1987). Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 37, 1097-1102. doi: 10.1212/WNL.37.7.1097.
95. Papadopoulos, D., Dukes, S., Patel, R., Nicholas, R., Vora, A., and Reynolds, R. (2009). Substantial archaeocortical atrophy and neuronal loss in multiple sclerosis. Brain Pathol. 19, 238-253. doi: 10.1111/j.1750-3639.2008.00177.x.
96. Pavitt, G. D., and Proud, C. G. (2009). Protein synthesis and its control in neuronal cells with a focus on vanishing white matter disease. Biochem. Soc. Trans. 37, 1298-1310. doi: 10.1042/BST0371298.
97. Pfeiffer, S. E., Warrington, A. E., and Bansal, R. (1993). The oligodendrocyte and its many cellular processes. Trends Cell. Biol. 3, 191-197. doi: 10.1016/0962-8924(93)90213-K.
98. Popescu, B. F., and Lucchinetti, C. F. (2012). Pathology of demyelinating diseases. Annu. Rev. Pathol. 7, 185-217. doi: 10.1146/annurev-pathol-011811-132443.
99. Popko, B., and Baerwald, K. D. (1999). Oligodendroglial response to the immune cytokine interferon gamma. Neurochem. Res. 24, 331-338. doi: 10.1023/A:1022586726510.
100. Popko, B., Corbin, J. G., Baerwald, K. D., Dupree, J., and Garcia, A. M. (1997). The effects of interferon-gamma on the central nervous system. Mol. Neurobiol. 14, 19-35. doi: 10.1007/BF02740619.
101. Prineas, J. W., and Parratt, J. D. (2012). Oligodendrocytes and the early multiple sclerosis lesion. Ann. Neurol. 72, 18-31. doi: 10.1002/ana.23634.
102. Qi, L., Yang, L., and Chen, H. (2011). Detecting and quantitating physiological endoplasmic reticulum stress. Methods Enzymol. 490, 137-146. doi: 10.1016/B978-0-12-385114-7.00008-8.
103. Ramana, C. V., Gil, M. P., Schreiber, R. D., and Stark, G. R. (2002). Stat1-dependent and-independent pathways in IFN-gamma-dependent signaling. Trends Immunol. 23, 96-101. doi: 10.1016/S1471-4906(01)02118-4.
104. Ren, Z., Wang, Y., Tao, D., Liebenson, D., Liggett, T., Goswami, R., et al. (2011). Overexpression of the dominant-negative form of interferon regulatory factor 1 in oligodendrocytes protects against experimental autoimmune encephalomyelitis. J. Neurosci. 31, 8329-8341. doi: 10.1523/JNEUROSCI.1028-11.2011.
105. Scheper, G. C., Proud, C. G., and van der Knaap, M. S. (2006). Defective translation initiation causes vanishing of cerebral white matter. Trends Mol. Med. 12, 159-166. doi: 10.1016/j.molmed.2006.02.006.
106. Schröder, M. (2008). Endoplasmic reticulum stress responses. Cell Mol. Life Sci. 65, 862-894. doi: 10.1007/s00018-007-7383-5.
107. Shen, J., Chen, X., Hendershot, L., and Prywes, R. (2002). ER stress regulation of ATF6 localization by dissociation of BiP/GRP78 binding and unmasking of Golgi localization signals. Dev. Cell 3, 99-111. doi: 10.1016/S1534-5807(02)00203-4.
108. Siffrin, V., Vogt, J., Radbruch, H., Nitsch, R., and Zipp, F. (2010). Multiple sclerosis-candidate mechanisms underlying CNS atrophy. Trends Neurosci. 33, 202-210. doi: 10.1016/j.tins.2010.01.002.
109. Southwood, C. M., Garbern, J., Jiang, W., and Gow, A. (2002). The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron 36, 585-596. doi: 10.1016/S0896-6273(02)01045-0.
110. Sriburi, R., Jackowski, S., Mori, K., and Brewer, J. W. (2004). XBP1: a link between the unfolded protein response, lipid biosynthesis, and biogenesis of the endoplasmic reticulum. J. Cell. Biol. 167, 35-41. doi: 10.1083/jcb.200406136.
111. Steinman, L. (1999). Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Neuron 24, 511-514. doi: 10.1016/S0896-6273(00)81107-1.
112. Stidworthy, M. F., Genoud, S., Suter, U., Mantei, N., and Franklin, R. J. (2003). Quantifying the early stages of remyelination following cuprizone-induced demyelination. Brain Pathol. 13, 329-339. doi: 10.1111/j.1750-3639.2003.tb00032.x.
113. Stockwell, S. R., Platt, G., Barrie, S. E., Zoumpoulidou, G., Te Poele, R. H., Aherne, G. W., et al. (2012). Mechanism-based screen for G1/S checkpoint activators identifies a selective activator of EIF2AK3/PERK signalling. PLoS ONE 7:e28568. doi: 10.1371/journal.pone.0028568.
114. Tabas, I., and Ron, D. (2011). Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat. Cell. Biol. 13, 184-190. doi: 10.1038/ncb0311-184.
115. Trapp, B. D., and Nave, K. A. (2008). Multiple sclerosis: an immune or neurodegenerative disorder? Annu. Rev. Neurosci. 31, 247-269. doi: 10.1146/annurev.neuro.30.051606.094313.
116. Tsaytler, P., Harding, H. P., Ron, D., and Bertolotti, A. (2011). Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis. Science 332, 91-94. doi: 10.1126/science.1201396.
117. van der Star, B. J., Vogel, D. Y., Kipp, M., Puentes, F., Baker, D., and Amor, S. (2012). In vitro and in vivo models of multiple sclerosis. CNS Neurol. Disord. Drug Targets 11, 570-588. doi: 10.2174/187152712801661284.
118. Vigeveno, R. M., Wiebenga, O. T., Wattjes, M. P., Geurts, J. J., and Barkhof, F. (2012). Shifting imaging targets in multiple sclerosis: from inflammation to neurodegeneration. J. Magn. Reson. Imaging. 36, 1-19. doi: 10.1002/jmri.23578.
119. Vogt, J., Paul, F., Aktas, O., Müller-Wielsch, K., Dörr, J., Dörr, S., et al. (2009). Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis. Ann. Neurol. 66, 310-322. doi: 10.1002/ana.21719.
120. Walter, P., and Ron, D. (2011). The unfolded protein response: from stress pathway to homeostatic regulation. Science 334, 1081-1086. doi: 10.1126/science.1209038.
121. Wang, L., Popko, B., Tixier, E., and Roos, R. P. (2014). Guanabenz, which enhances the unfolded protein response, ameliorates mutant SOD1-induced amyotrophic lateral sclerosis. Neurobiol. Dis. 71, 317-324. doi: 10.1016/j.nbd.2014.08.010.
122. Wang, M., and Kaufman, R. J. (2014). The impact of the endoplasmic reticulum protein-folding environment on cancer development. Nat. Rev. Cancer 14, 581-597. doi: 10.1038/nrc3800.
123. Wang, S., and Kaufman, R. J. (2012). The impact of the unfolded protein response on human disease. J. Cell. Biol. 197, 857-867. doi: 10.1083/jcb.201110131.
124. Way, S. W., Podojil, J. R., Clayton, B. L., Zaremba, A., Collins, T. L., Kunjamma, R. B., et al. (2015). Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeutic. Nat. Commun. 6, 6532. doi: 10.1038/ncomms7532.
125. Wheatley, A. K., Kramski, M., Alexander, M. R., Toe, J. G., Center, R. J., and Purcell, D. F. (2011). Co-expression of miRNA targeting the expression of PERK, but not PKR, enhances cellular immunity from an HIV-1 Env DNA vaccine. PLoS ONE 6:e18225. doi: 10.1371/journal.pone.0018225.
126. Wheeler, R. D., and Owens, T. (2005). The changing face of cytokines in the brain: perspectives from EAE. Curr. Pharm. Des. 11, 1031-1037. doi: 10.2174/1381612053381657.
127. Willenborg, D. O., Fordham, S., Bernard, C. C., Cowden, W. B., and Ramshaw, I. A. (1996). IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157, 3223-3227.
128. Wollmann, R. L., Szuchet, S., Barlow, J., and Jerkovic, M. (1981). Ultrastructural changes accompanying the growth of isolated oligodendrocytes. J. Neurosci. Res. 6, 757-769. doi: 10.1002/jnr.490060610.
129. Woo, C. W., Cui, D., Arellano, J., Dorweiler, B., Harding, H., Fitzgerald, K. A., et al. (2009). Adaptive suppression of the ATF4-CHOP branch of the unfolded protein response by toll-like receptor signalling. Nat. Cell. Biol. 11, 1473-1480. doi: 10.1038/ncb1996.
130. Yamamoto, K., Takahara, K., Oyadomari, S., Okada, T., Sato, T., Harada, A., et al. (2010). Induction of liver steatosis and lipid droplet formation in ATF6alpha-knockout mice burdened with pharmacological endoplasmic reticulum stress. Mol. Biol. Cell. 21, 2975-2986. doi: 10.1091/mbc.E09-02-0133.
131. Yan, J., and Greer, J. M. (2008). NF-kappa B, a potential therapeutic target for the treatment of multiple sclerosis. CNS Neurol. Disord. Drug Targets 7, 536-557. doi: 10.2174/187152708787122941.
132. Zhang, K., and Kaufman, R. J. (2008). From endoplasmic-reticulum stress to the inflammatory response. Nature 454, 455-462. doi: 10.1038/nature07203.